This company is engaged in pharmaceutical industry,_focusing_on research,_development,_production, and sales of pharmaceutical_products. It conducts_business_from its_registered_head office_located in CITY,_COUNTRY. The company was_founded in DATE and specialises in contrast agents, central_nervous_system products, and oral anti-diabetic drugs.The company is strategically diversifying its product_portfolio by expanding research and development initiatives in central_nervous_system and endocrine CRIMINAL_CHARGE. With a contrast_agent production line adhering_to ORGANIZATION standards, equipped_with advanced international facilities, the company ensures its products meet global quality benchmarks. Additionally,_it has extended its reach by establishing a traditional_NATIONALITY_medicine extraction and API production base in LOCATION_LOCATION. The inclusion of ORGANIZATION ORGANIZATION ORGANIZATION ORGANIZATION ORGANIZATION ORGANIZATION as a holding subsidiary further reinforces the company 's integrated business TITLE, emphasizing " API preparation " for contrast_agent products. The company envisions consolidating its leading_position in the contrast_agent market, cultivating a corporate brand, achieving product diversification, and delivering sustained value growth for its customers and investors.